[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100526333":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":19,"responsibleParty":60,"collaborators":62,"id":67,"slug":68,"hasResults":69,"nctId":70,"briefTitle":71,"officialTitle":71,"acronym":7,"eligibilityCriteria":72,"healthyVolunteers":69,"sex":73,"minAge":74,"maxAge":7,"enrollmentInfo":75,"targetDuration":7,"studyType":78,"phases":7,"briefSummary":79,"conditions":80,"keywords":7,"overallStatus":22,"whyStopped":7,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":91},{"fullName":5,"class":6},"University of Calgary","OTHER",null,[9],{"name":10,"affiliation":11,"role":12},"Caitlin Yeo, MD","Alberta Health services","PRINCIPAL_INVESTIGATOR",[14],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Elleine Allapitan","CONTACT","403-220-8440","elleine.allapitan@ucalgary.ca",[20],{"facility":21,"status":22,"city":23,"state":24,"zip":25,"country":26,"countryCode":27,"cosmosGeoPoint":28,"geoPoint":33,"contacts":34},"Foothills Medical Centre","RECRUITING","Calgary","Alberta","T2N 1N4","Canada","CA",{"type":29,"coordinates":30},"Point",[31,32],-114.08529,51.05011,{"lat":32,"lon":31},[35,37,40,42,44,46,48,50,52,54,56,58],{"name":15,"role":16,"phone":36,"phoneExt":7,"email":7},"4032208440",{"name":38,"role":39,"phone":7,"phoneExt":7,"email":7},"Adrian Harvey, MD","SUB_INVESTIGATOR",{"name":41,"role":39,"phone":7,"phoneExt":7,"email":7},"Janice Pasieka, MD",{"name":43,"role":39,"phone":7,"phoneExt":7,"email":7},"Shamir Chandarana, MD",{"name":45,"role":39,"phone":7,"phoneExt":7,"email":7},"Robert Hart, MD",{"name":47,"role":39,"phone":7,"phoneExt":7,"email":7},"Wayne Matthews, MD",{"name":49,"role":39,"phone":7,"phoneExt":7,"email":7},"Martin Hyrcza, MD\u002FPhD",{"name":51,"role":39,"phone":7,"phoneExt":7,"email":7},"Moosa Khalil, MD",{"name":53,"role":39,"phone":7,"phoneExt":7,"email":7},"Anthony Magliocco, MD",{"name":55,"role":39,"phone":7,"phoneExt":7,"email":7},"Karen Kopciuk, PhD",{"name":57,"role":39,"phone":7,"phoneExt":7,"email":7},"Tasnima Abedin, PhD",{"name":59,"role":39,"phone":7,"phoneExt":7,"email":7},"Faisal Khan, PhD",{"type":61,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[63,66],{"name":64,"class":65},"Qualisure Diagnostics Inc.","UNKNOWN",{"name":11,"class":6},"100526333","concordance-of-molecular-classification-based-on-fine-needle-biopsy-fnb-and-surgical-samples-100526333",false,"NCT06133374","Concordance of Molecular Classification Based on Fine Needle Biopsy (FNB) and Surgical Samples","Inclusion Criteria:\n\n* Age ≥ 18 years\n* A diagnosis of papillary thyroid cancer based on a fine needle biopsy (FNB) interpreted as a Bethesda V or VI cytology\n* A diagnosis of Atypia of Undetermined Significance (AUS) or Follicular Lesion of Undetermined Significance (FLUS) interpreted as Bethesda III or IV cytology (indeterminate nodule) ThyroSpec positive for BRAFV600E, TERT, rearrangements in BRAF, RET, NTRK1, NTRK3, RAS + TERT, RAS + EIF1AX, AKT1, PI3CA, CTNNB1, EGFR, rearrangements in ALK\n* Tumor size \\> 1 cm in maximal diameter on imaging prior to surgery\n* The patient is an operative candidate\n* The patient has provided consent\n\nExclusion Criteria:\n\n* History of radiation to the neck for situations such as medical radiation, radiation exposure in a work environment (nuclear power plant\u002Freactor), or radiation exposure through release of radioactive materials into the nearby environment from a nuclear power plant\u002Freactor.\n* Unable or unwilling to have a fine needle biopsy\n* Unwilling to undergo thyroidectomy\n* Final pathology does not demonstrate papillary thyroid cancer\n* Cases where there is no clear dominant nodule\n* Cases where there are multiple nodules that preclude sampling of a defined nodule","ALL","18 Years",{"count":76,"type":77},130,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to determine whether results from a fine needle biopsy are the same as results from a larger sample that is acquired from the surgical pathology using the Thyroid GuidePx® test in patients with papillary thyroid carcinoma.",[81],"Papillary Thyroid Cancer","2026-01-13",{"date":84,"type":85},"2026-01-15","ACTUAL",{"date":87,"type":85},"2024-07-01",{"date":89,"type":77},"2028-05-30",{"name":5,"class":6},1]